Molecular basis and biomarkers of disease activity

In: Endometriosis · 2020 · pp. 13–21 · doi:10.1201/9780429448980-4 · W3010465635
Review OA: closed CC0
View on OpenAlex View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-29 ⓘ

This chapter discusses the potential roles of proposed noninvasive and minimally invasive biomarkers in diagnosing endometriosis, noting that no single marker currently replaces histopathological diagnosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis refers to non-uterine, ectopic localization of endometrial tissue in any other tissue or organ of the body. Establishing an early diagnosis of this complex disease is essential for prompt management in women with endometriosis. Advances in the research have led to identification of a number of noninvasive and/or minimally invasive biomarkers for early diagnosis of endometriosis. However, despite a large number of biomarkers being available, promising results are sparse, and to date, no single biomarker is capable of accurately diagnosing endometriosis which can replace histopathological diagnosis. In this chapter, the authors discuss the potential roles of all the proposed biomarkers in the diagnosis of endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK